Growth hormone & body composition
Tesamorelin
Also written: Tesamorelin acetate
One of the few peptides in this category with an approved drug counterpart — which makes the approval question sharper, not simpler.
Tesamorelin is a synthetic peptide, a stabilised analogue of a naturally occurring releasing hormone. It is worth a careful page because, unlike most of this category, a tesamorelin drug product has an approved form for a specific, narrow medical indication — which makes the "is it approved" conversation sharper rather than simpler.
Approved for what, exactly
This is where precision matters and gets lost. An approved drug product is approved for a specific indication, in a specific formulation, made to a specific standard. That a molecule has an approved counterpart somewhere does not mean that a vial of the same-named material from a supply channel carries that approval, that formulation, or that indication. The name being the same is not the approval being the same, and eliding the two is one of the most common moves in this category.
What the format changes
Supplied lyophilized and reconstituted, in several vial sizes and also as combination products. The usual handling and documentation questions apply, with the added care that the approved-counterpart fact makes the labelling and intended-use questions more important, not less.
What to ask before ordering
The standard questions, plus the sharp one: is this material the approved drug product, or a compound sharing its name — and what does the label state as intended use. A supplier should answer that plainly. A managed answer is itself the answer.
What we are not claiming
That any material we discuss carries an approval it does not hold, or that it is appropriate for any use in any person. The existence of an approved counterpart is a fact about a drug product, not an endorsement of anything else bearing the name.
Questions we get about Tesamorelin
- Is Tesamorelin FDA approved?
- A tesamorelin drug product has an approved form for a specific, narrow indication. That does not mean a same-named vial from a supply channel carries that approval, formulation, or indication — the name being shared is not the approval being shared.
- What is the sharp question to ask?
- Whether the material is the approved drug product or a compound sharing its name, and what the label states as intended use.
- Does an approved counterpart make it safe to assume things?
- No. It makes the labelling and intended-use questions more important, because it is exactly the situation where the name and the approval are most likely to be run together.
Read next from the library
- What a peptide actually isNot a drug class, not a supplement, not a hormone. A length. Once that lands, most of the confusion in this category goes away.
- "Is it FDA approved?" is usually the wrong questionNot because the answer is uncomfortable, but because approval, registration, clearance and certification are four different things — and only one of them is usually on offer.
- How to read a certificate of analysisThe document that separates a supply chain you can defend from one you are trusting. Six fields, and one question that matters more than the rest.